Healthcare -
Medical - Devices - NASDAQ - US
$ 5.15
-9.01 %
$ 663 M
Market Cap
-64.37
P/E
Price Target
Average
118.45%
Revenue Forecast
Estimate
17.98%
EBIT
Estimate
39.31%
Net Income
Estimate
67.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytek Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CTKB of $11.2 , with forecasts ranging from
a
low of
$8.5 to a high of $16 .
CTKB Lowest Price Target
Wall Street Target
8.5 USD
65.05%
CTKB Average Price Target
Wall Street Target
11.2 USD
118.45%
CTKB Highest Price Target
Wall Street Target
16 USD
210.68%
REVENUE FORECAST
Revenue Forecast Chart CTKB
EBIT FORECAST
EBIT Forecast Chart CTKB
NET INCOME FORECAST
Net Income Chart CTKB